Mar 31, 2026
The Board of Directors of your Company (Board) are pleased to present their report and the audited accounts for the financial year
ended March 31,2026.
The financial performance for the year under review of your Company is summarized below (in f lakhs):
|
Particulars |
Standalone |
Consolidated |
||
|
2025-26 |
2024-25 |
2025-26 |
2024-25 |
|
|
Revenue from Operations |
7,364.75 |
6,940.04 |
32,615.06 |
29,227.34 |
|
Other Income |
450.43 |
381.08 |
395.68 |
582.98 |
|
Total Income |
7,815.18 |
7,321.12 |
33,010.75 |
29,810.32 |
|
Total Expense |
6,635.59 |
6,562.74 |
28,484.84 |
25,593.34 |
|
Profit Before Taxes and Exceptional Items |
1,179.59 |
758.39 |
4,525.90 |
4,216.98 |
|
Profit Before Taxes after Exceptional Items |
1,179.59 |
758.39 |
4,525.90 |
4,217.43 |
|
Provision for Taxation including Deferred Tax |
140.70 |
155.53 |
1,047.87 |
1,125.53 |
|
Profit After Tax |
1,038.90 |
602.86 |
3,478.03 |
3,091.45 |
|
Profit for the year |
1,038.90 |
602.86 |
3,478.03 |
3,091.90 |
The Board has recommended a final dividend of T1.25 (Rupee One and Paise Twenty-Five only) per equity share of T5 (Rupees
Five only) each, aggregating to T336.20 lakhs for the financial year ended March 31, 2026. The dividend is subject to approval of
members at the ensuing Annual General Meeting (AGM) and shall be subject to deduction of income tax at source.
Your Company is engaged in the manufacturing and sale of specialty chemicals and provides comprehensive solutions in the
areas of water treatment, industrial and institutional cleaning and hygiene, and high-performance construction chemicals. There
have been no changes in the business of the Company.
The movement of Equity Capital is as under:
|
Particulars |
Number of |
Equity Share |
|
Equity Capital as on March 31,2025 |
10,000 |
50,000 |
|
Allotment of shares on May 13, 2025, as per composite scheme of arrangement |
2,68,96,576 |
13,44,82,880 |
|
Cancellation of initial share capital held by Chembond Material Technologies Limited |
(10,000) |
(50,000) |
|
Equity Capital as on March 31,2026 |
2,68,96,576 |
13,44,82,880 |
In accordance to the NCLT approved scheme of arrangement 2,68,96,576 (Two Crores Sixty-Eight Lakhs Ninety-Six Thousand Five
Hundred Seventy-Six) new equity shares of your Company having face value T5 each (Rupees Five) were allotted to the eligible
shareholders holding shares of Chembond Material Technologies Limited (formerly Chembond Chemicals Limited)("Demerged
Company") as on the Record Date i.e. May 9, 2025 at a share entitlement ratio of 1:2 (two new equity shares of your Company for
every one share of Demerged Company held).
The Allotment Committee noted the cancellation and reduction of the entire pre-Scheme paid-up share capital of the Resulting
Company, comprising 10,000 (Ten Thousand) fully paid-up equity shares of face value T5 each ("Resulting Company Cancelled
Shares"), which were held entirely by Chembond Material Technologies Limited (formerly Chembond Chemicals Limited),
("Demerged Company"). The reduction in share capital of
the Resulting Company is an integral part of the scheme in
accordance with the provision section 66 of the Companies
Act 2013 and/or any other applicable provision of the Act
without any further act or deed on the part of Resulting
Company and without any approval or acknowledgement of
any third party. With the allotment of the new equity shares
and the cancellation of the Resulting Company Cancelled
Shares, as outlined above, the Resulting Company will no
longer be considered a WOS of the Demerged Company, in
accordance with the provisions of the Scheme. Your Company
has only one class of Equity Shares and it has neither issued
shares with differential rights for dividend, voting or otherwise,
nor issued shares (including sweat equity shares) to the
employees or Directors of the Company, under any Scheme.
No disclosure is required under Section 67(3)(c) of the Act in
respect of voting rights not exercised directly by the employees
or Key Managerial Personnel of the Company as the provisions
of the Section are not applicable.
The Company has not accepted any deposits within the
meaning of Section 73 of the Companies Act, 2013 read with
the Companies (Acceptance of Deposits) Rules, 2014, as
amended from time to time, during the year under review.
The Board consists of six Directors comprising of one Non¬
Executive, Non-Independent Director, one Executive Director,
and four Independent Directors, of whom one is a Woman. The
Chairman of the Board is an Executive Director and is a part of
the Promoters and Promoter Group.
In accordance with the provisions of Section 152(6) of the
Companies Act, 2013, Mr. Sameer V. Shah (DIN:00105721)
Non-Executive Director, retires by rotation at the ensuing
Annual General Meeting, and being eligible, has offered
himself for re-appointment. His profile is detailed in the
Corporate Governance Report, which forms a part of this
Annual Report.
The Board appointed Mrs Anuradha Paraskar (DIN:02331564)
and Prof. Aniruddha B. Pandit (DIN:02471158) as Non¬
Executive Independent Directors of the Company with effect
from April 1,2025, for a term of five year. The Board appointed
Mr. Sushil U. Lakhani (DIN:01578957) and Mr. Mahendra
K. Ghelani (DIN:01108297) as Non-Executive Independent
Directors of the Company with effect from May 6, 2025, for a
period of five year. Their appointments were duly approved by
the Members through an Extraordinary General Meeting by the
requisite majority.
In terms of key managerial changes, the Company appointed
Mrs. Prachi Mahadik as its Chief Financial Officer with effect
from April 1, 2025, and Mr. Kiran Mukadam as its Company
Secretary and Compliance Officer with effect from May 6,
2025.
Pursuant to the provisions of Section 203 of the Companies
Act, 2013, Mr. Nirmal V. Shah, Chairman and Managing
Director; Mrs Prachi Mahadik, Chief Financial Officer; and Mr.
Kiran Mukadam, Company Secretary and Compliance Officer
are the Key Managerial Personnel of the Company as on the
date of this Report.
All the Independent Directors of the Company have furnished
a declaration to the effect that they meet the criteria of
independence as provided in Section 149(6) of the Act
and Regulation 16(1)(b) and Regulation 25 of the Listing
Regulations. The Board opines that all the Independent
Directors possess the integrity, expertise, experience, and
proficiency required to be Independent Directors of the
Company, fulfil the conditions of independence as specified
in the Act and the Listing Regulations, are independent of
the management, and have complied with the Code for
Independent Directors as prescribed in Schedule IV of the
Act. Declaration of their independence as required under the
Listing Regulations have also been received from the Director.
The Company has a policy for the appointment and
remuneration of Directors and matters under Section 178(3)
of the Act. This policy is uploaded on the Companyâs website,
and its salient features have been disclosed in the Corporate
Governance section of this Annual Report.
Seven (7) Board meetings were held in the year, details are
furnished in the Corporate Governance Report.
In accordance with the Act and the corporate governance
requirements under the Listing Regulations, the Board
evaluated its own performance, that of its Committees, and
individual Directors for the year. Factors such as composition,
structure, process effectiveness, quality of information, and
overall functioning were considered. The Board and the NRC
also reviewed the performance of individual Directors based
on attendance, preparedness, and contributions at Board
and Committee meetings. At their separate meeting held
on March 06, 2026, the Independent Directors reviewed the
performance of the Non-Independent Directors, the Board
as a whole, and the Chairman, considering the views of the
Executive and Non-Executive Director. They also assessed
the quality, quantity, and timeliness of information flow to the
Board for effective discharge of its duties.
The Board confirms that pursuant to Section 134(5) of the Act,
and to the best of its knowledge and ability, for the FY 2025-26:
a) the applicable accounting standards have been followed
and there is no material departure in the preparation of
the annual accounts;
b) accounting policies were selected and applied
consistently, and judgments and estimates made were
reasonable and prudent to give a true and fair view of the
state of affairs and the profit of the Company;
c) adequate accounting records were maintained for
safeguarding the assets of the Company and for preventing
and detecting fraud and irregularities, in accordance with
the provisions of the Act;
d) annual accounts were prepared on a going concern basis;
e) adequate and effective internal financial controls were
laid down and followed in the operations; and
f) proper and adequate systems were devised and were
operating effectively in compliance with the provisions of
all applicable laws.
The details in respect of role / powers / composition of the
Audit Committee and other information are included in the
Corporate Governance Report forming a part of this Annual
Report.
The Statutory Auditors of the Company - Bathiya & Associates
LLP, Chartered Accountants (FRN:101046W/W100063)
(Auditors) - were appointed for a 5 (five) consecutive year
term (first term) at the 1st Annual General Meeting (AGM) held
on July 20, 2024, at a remuneration mutually agreed upon
by the Board and the Auditor Effective December 17, 2024,
their name has changed to S H B A & Co LLP. The first term
of the Auditors concludes at the 6th AGM i.e. in FY 2029. The
Auditors Report on the financial statements of the Company
is a part of this Annual Report. There is no modified opinion,
qualification, reservation, adverse remark or disclaimer given
by the Auditors for the year under review. The observations
and comments given in their report read together with the
Notes to Accounts are self-explanatory and hence do not call
for any further explanation or comments under Section 134 (f)
(i) of the Act.
The Board appointed Mr. Virendra G. Bhatt, Practicing
Company Secretary (CP:124) to undertake the Secretarial
Audit of the Company for a period of five (5) years from FY 2025¬
26 to FY 2029-30. This was done pursuant to the provisions of
Section 204 of the Act and the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014 read with
Regulation 24A of SEBI Listing Regulations, and under approval
of the shareholders obtained at the 2nd AGM of the Company
held on August 14, 2025. Annexure E contains the Secretarial
Audit Report in Form MR-3 along with the Secretarial Audit
Report of material unlisted subsidiaries for the FY ended
31st March 2026. The Company has complied with the
applicable Secretarial Standards issued by the Institute of
Company Secretaries of India (ICSI) during the year under
review. There are no qualifications, reservations, adverse
remarks or disclaimers given by the Secretarial Auditor.
In terms of Section 118(10) of the Act, the Company is
compliant to the Secretarial Standards issued by the ICSI.
Board Meetings, General Meetings, and systems as such were
adequate and operating effectively.
Fraud Reporting
The Statutory Auditors, Cost Auditors and Secretarial Auditors
have not reported any instances of fraud committed by officers
or employees of the Company to the Audit Committee. As per
Section 143(12) of the Act, details of such instances need to
be mentioned in the Annual Report.
The Company operates its domestic and international
business through wholly owned or step-down subsidiaries.
The financial performance of these companies is given in
Annexure A - form AOC 1. Chembond Water Technologies
Ltd, a wholly owned subsidiary of your Company transferred
its entire shareholding in Rewasoft Solutions Pvt Ltd and
effective January 1, 2026, Rewasoft ceased to be a step-
down associate. The standalone and consolidated financial
statements, relevant documents, and audited financial
statements of subsidiaries, are available on the Companyâs
website https://www.chembondindia.com/subsidiary-
financials/ in compliance with Section 136 of the Act.
All transactions entered with related parties during the
financial year were in the ordinary course of business on an
armâs length basis and do not attract the provisions of Section
188(1) of the Act. Suitable disclosures as required by the
Indian Accounting Standards (Ind AS-24) have been made in
the notes to the financial statements. The Companyâs RPT
policy is available on its website https://www.chembondindia.
com/all-policies/. in compliance to the provisions of Section
136 of the Act. Annexure B - form AOC-2 contains details of
material RPT for the year as prescribed by Section 134(3)(h) of
the Act and Rule 8 of the Companies (Accounts) Rules, 2014.
Annexure C of this report contains particulars required to be
disclosed under Section 134(3)(m) of the Act read with Rule
8(3) of the Companies (Account) Rules, 2014, amended from
time to time.
The Companyâs CSR policy (available on its website https://
www.chembondindia.com/all-policies/) prioritizes fulfilling
CSR spend commitments in certain focus areas. Constituted
by the Board pursuant to Section 135 of the Act read with the
Companies CSR Policy Rules, 2014 amended periodically,
the CSR Committee spent ^ 13.55 lakhs during the year
enumerated in Annexure D.
Information regarding Directorsâ remuneration policy, criteria
and other matters as per sub-section (3) of Section 178 are
provided in the Corporate Governance Report. Annexure F
contains the prescribed disclosures and details pursuant
to Section 197 of the Companies Act, 2013 read with Rule
5(1) of the Companies (Appointment and Remuneration of
Managerial Personnel) Rules, 2014.
None of the employees have remuneration exceeding the
prescribed limits set under Section 197 of the Act read with
Rule 5(2) of the Companies Rules, 2014 as amended expect
Mr Nirmal Shah. The prescribed details are mentioned in
Annexure F. In line with Section 136 of the Act, this Annual
Report is being sent to the members and others entitled
thereto without information and details of employees. The
particulars are available for inspection by members during
business hours on working days at the registered office of the
Company up to the date of the ensuing AGM.
The Company has adopted all the applicable policies in line
with the provisions of the Act and the Listing Regulations.
Policies are available on the Company website https://www.
chembondindia.com/all-policies/. All Directors and senior
management personnel have affirmed their adherence to
the provisions of the Code of Conduct in FY 2025-26. The
Companyâs policy on Directorsâ appointment, remuneration
and other matters provided in Section 178(3) of the Act forms
a part of the Nomination and Remuneration Policy and can be
found in the Corporate Governance Report.
The Company has voluntarily constituted a Risk Management
Committee (RMC) to prepare, review and monitor a risk
management plan. The RMC meets on a required basis
to identify and review critical risks and reports changes
to the Board and Audit Committee in detail. The Risk
Management Policy can be viewed on the Company website
https://www.chembondindia.com/all-policies/
Your Company has an adequate system of internal controls
in place to ensure compliance with various policies,
practices and statutes. The Company also maintains robust
internal financial control systems and processes that are
commensurate with the size, nature, geographical spread and
complexities of its operation both at entity and process levels.
The Board is responsible for the same as per Section 134 of
the Act.
Management Discussion and Analysis Report forming a part
of this Annual Report is included as stipulated by the Listing
Regulations.
A Corporate Governance Report covering compliances with
stipulations and requirements of Regulation 34(3) read with
Schedule V of the Listing Regulations forms a part of this
Annual Report. The same has been reviewed and certified
by Mr. Virendra G. Bhatt, Practicing Company Secretary
and Secretarial Auditor of the Company and a compliance
certificate is included herein. The Company has formulated a
Whistle Blower Policy thereby establishing a vigil mechanism
for Directors and permanent employees for reporting genuine
concerns or grievances, if any, about unethical behaviour,
actual or suspected fraud or violation of the Companyâs
Code of Conduct or policies. It also provides adequate
safeguards against the victimization of employees and allows
direct access to the chairperson of the Audit Committee in
appropriate or exceptional cases. Details are furnished in the
Corporate Governance Report. The policy is available on the
Companyâs website https://www.chembondindia.com/all-
policies/
Details of loans, guarantees and investments have been
disclosed in the financial statements.
Chembond Material Technologies Limited (formerly
Chembond Chemicals Limited)("Demerged Company") held
42,764 equity shares in the IEPF established by the Central
Government. Consequent to the scheme of arrangement
coming into effect, Chembond Chemicals Limited (formerly
Chembond Chemical Specialties Ltd)has transferred 85,528
equity shares as per the share entitlement ratio of the scheme
of arrangement to the IEPF and Form IEPF-4 has been filed on
September 16, 2025. The list of shareholders whose shares
or dividends have been transferred to the IEPF has been
uploaded on the Companyâs website. Members / Claimants
can make an application to IEPF Authority in Form IEPF-5
(available on www.iepf.gov.in) and reclaim such transferred
shares or dividends. The Member / Claimant can file only one
consolidated claim in a Financial Year as per the IEPF Rules.
The Annual Return as per Section 92(3) and Section 134(3)
(a) of the Act, and Form MGT-7 prescribed by the Companies
(Management and Administration) Rules, 2014, is available at
https://www.chembondindia.com/forms-and-notices/
The Company has a Policy for Prevention of Sexual Harassment
(at: https://www.chembondindia.com/all-policies) meeting
the requirements of the Sexual Harassment of Women at
Workplace (Prevention, Prohibition and Redressal) Act,
2013. All employees (permanent, contractual, temporary
and trainees) are covered under this policy and have been
provided training on the same. An Internal Complaints
Committee (ICC) has been set up to redress complaints
received regarding sexual harassment. During the year under
review, no complaints were received.
The Company is committed to ensuring a safe, inclusive,
and supportive workplace for women employees. Necessary
internal systems and HR policies are aligned to uphold the
spirit and letter of the Maternity Benefit Act, 1961, including
all amendments and rules framed thereunder, and is fully
compliant with the provisions.
The Business Responsibility and Sustainability Report as
stipulated in Section 34 of the Listing Regulations is not
applicable to the Company.
Except for changes in the share capital, name of the
Company, and some scheme of arrangement related points
disclosed elsewhere in this report, no material changes
and commitments affecting the financial position of your
Company have occurred between the end of the financial year
of the Company and the date of this Report.
During the year under review, there is no pending litigation
against the Company. There have been no significant and
material orders passed by the Regulators or Courts or
Tribunals impacting the going concern status of the Company
and its future operations.
There are no proceedings or appeals pending, and no
applications have been filed during the year and till the date of
this report under the Insolvency and Bankruptcy Code, 2016.
No One-time settlement or revaluation was done while availing
or discharging loans from Banks / Financial Institutions during
the year.
The Company recognizes the need to have well-equipped
R&D facilities to meet customer requirements and develop
cutting edge products. As a natural corollary, your Company
continues to invest in a R&D programme with processes that
suit the business and strategy of the Company.
The Board of Directors places on record its sincere appreciation
for the hard work, dedication, and commitment demonstrated
by its personnel across all levels of the organization. The
Board also gratefully acknowledges the continued support
and cooperation extended by the bankers, suppliers, business
partners, members, various government authorities, and all
other stakeholders who have contributed to the Companyâs
progress.
By order of the Board of Directors of
Chembond Chemicals Limited
(formerly Chembond Chemical Specialties Limited)
Chairman and Managing Director
16th May 2026, Navi Mumbai DIN 00083853
Mar 31, 2025
Your Directorsâ take pleasure in presenting the Annual Report on the business and operations of your Company together with the
audited financial statements for the year ended 31st March, 2025.
Your directors are pleased to inform that the Composite Scheme of Arrangement between Chembond Material Technologies
Limited (formerly Chembond Chemicals Limited) (âDemerged Companyâ / âTransferee Companyâ) and Chembond Chemicals
Limited (formerly Chembond Chemical Specialties Limited) (âResulting Companyâ) and Chembond Clean Water Technologies
Limited (âTransferor Company No. 1â Or âCCWTLâ) and Chembond Material Technologies Private Limited (âTransferor Company
No. 2â Or âCMTPLâ) and Phiroze Sethna Private Limited (âTransferor Company No. 3â Or âPSPLâ) and Gramos Chemicals (India)
Private Limited (âTransferor Company No. 4â Or âGCIPLâ) and their respective shareholders has been sanctioned by the Honâble
National Company Law Tribunal, Mumbai Bench (NCLT) vide its order dated April 7, 2025 and certified copy of the order was
received by Demerger Company on April 22, 2025. The Scheme of Arrangement became effective upon filing the NCLT order with
the Registrar of Companies on May 3, 2025. In accordance with the Scheme, the âAppointed Dateâ is April 1,2024.
The restated financial performance of your Company is as summarized below for the year under review:
|
Particulars |
Standalone |
Consolidated |
||
|
2024-25 |
2023-24 |
2024-25 |
2023-24 |
|
|
Revenue from Operations |
6940.04 |
6886.05 |
29227.34 |
28323.95 |
|
Other Income |
381.08 |
376.54 |
582.98 |
370.43 |
|
Total Income |
7321.12 |
7262.59 |
29810.32 |
28694.38 |
|
Total expense |
6562.72 |
6162.46 |
25593.34 |
24449.58 |
|
Profit before taxes and exceptional items |
758.39 |
1103.13 |
4216.98 |
4244.80 |
|
Profit before taxes after exceptional items |
758.39 |
1103.13 |
4216.98 |
4244.80 |
|
Provision for taxation for the year including deferred |
155.53 |
360.10 |
1125.53 |
1242.51 |
|
Profit after Taxes |
602.86 |
743.03 |
3091.45 |
3001.79 |
|
Share of Profit(loss) of Step Down Associate |
- |
- |
0.45 |
0.50 |
|
Profit for the year |
602.86 |
743.03 |
3091.90 |
3002.29 |
solutions for water treatment, industrial and institutional
cleaning and hygiene, and high-performance construction
chemicals.
The Board of Directors has recommended a final dividend
of T1.25 per share for the financial year ended 31st March
2025. This includes a special dividend of T0.50 per share to
commemorate the 50th anniversary of the founding of the
Chembond Group.
Except for the realignment resulting from the implementation
of the Composite Scheme of Arrangement duly approved by the
NCLT, Mumbai vide their order dated April 7, 2025 there is no
other change in the nature of business or the business line of
the Company. We are engaged in the manufacturing and sales
of specialty chemicals. Your Company offers comprehensive
The Board of Directors of the Company at its meeting held on 12th
December 2023 approved the Composite Scheme of Arrangement
between:
1. Chembond Chemicals Ltd, now known as Chembond Material
Technologies Ltd ("Demerged Company"/ "Transferee
Company"), and
2. Chembond Chemical Specialties Ltd, now known as
Chembond Chemicals Ltd ("Resulting Company"), and
3. Chembond Clean Water Technologies Ltd ("Transferor
Company No. 1" or "CCWTL"), and
4. Chembond Material Technologies Pvt Ltd ("Transferor
Company No. 2" or "CMTPL"), and
5. Phiroze Sethna Pvt Ltd ("Transferor Company No. 3" or
"PSPL"), and
6. Gramos Chemicals (India) Pvt Ltd ("Transferor Company no.
4" or "GCIPL"), and
7. their respective shareholders under Section 230-232 and
other applicable provisions of the Act.
The Scheme envisages the transfer of the construction chemicals
and water treatment ("CC & WT") businesses to its wholly
owned subsidiary ("WOS") Chembond Chemical Specialties
Ltd (since renamed as Chembond Chemicals Ltd) by way of
demerger and, post demerger amalgamation of CCWTL with the
Resulting Company. The National Company Law Tribunal (NCLT)
has approved the scheme vide its order dated April 7, 2025.
The Company has filed INC 28 on May 3, 2025, and accordingly,
the Scheme has become effective from Saturday, May 3, 2025.
Pursuant to Clause 42 of the Composite Scheme of Arrangement,
the name of the Company has been changed from ''Chembond
Chemical Specialties Ltd'' to ''Chembond Chemicals Ltd'' with effect
from June 24, 2025.
The movement of Equity Capital is as under:
|
Particulars |
No. of Equity |
Equity Share |
|
Equity Capital as on |
10000 |
50,000 |
|
Increase/ Decrease |
Nil |
Nil |
|
Equity Capital as on 31st |
10,000 |
50,000 |
|
Allotment of shares as |
2,68,96,576 |
13,44,82,880 |
|
Cancellation of original |
(10,000) |
(50,000) |
|
Equity Capital as on May |
2,68,96,576 |
13,44,82,880 |
Pursuant to and in accordance to the above-referred NCLT
approved Scheme, the Allotment Committee has allotted
2,68,96,576 (Two Crores Sixty-Eight Lakhs Ninety-Six
Thousand Five Hundred Seventy-Six) new equity shares of
face value T5/- each (Rupees Five) to the eligible shareholders
of Chembond Chemicals Ltd, now known as Chembond
Material Technologies Ltd, (âDemerged Companyâ ), at a share
entitlement ratio of 1:2 (two new equity share for every one
shares held) as on the record date, which was Friday, May 9,
2025.
The Allotment Committee noted the cancellation and
reduction of the entire pre-Scheme paid-up share capital of
the Resulting Company, comprising 10,000 (Ten Thousand)
fully paid-up equity shares of face value T5/- each (âResulting
Company Cancelled Sharesâ), which were held entirely by
Chembond Chemicals Ltd (âDemerged Companyâ). The
reduction in share capital of the Resulting Company is an
integral part of the scheme in accordance with the provision
section 66 of the Companies Act 2013 and/or any other
applicable provision of the Act without any further act or deed
on the part of Resulting Company and without any approval
or acknowledgement of any third party. With the allotment of
the new equity shares and the cancellation of the Resulting
Company Cancelled Shares, as outlined above, the Resulting
Company will no longer be considered a WOS of the Demerged
Company, in accordance with the provisions of the Scheme.
Your Company has only one class of Equity Shares and it has
neither issued shares with differential rights for dividend,
voting or otherwise, nor issued shares (including sweat equity
shares) to the employees or Directors of the Company, under
any Scheme. No disclosure is required under Section 67(3)(c)
of the Act in respect of voting rights not exercised directly by
the employees or Key Managerial Personnel of the Company
as the provisions of the Section are not applicable.
The Company is in the process of the listing of 2,68,96,576 (Two
Crores Sixty-Eight Lakhs Ninety-Six Thousand Five Hundred
Seventy-Six) new equity shares of face value T5/- each on BSE
Ltd [BSE] and the National Stock Exchange of India Ltd [NSE].
The shares will be listed upon receipt of the requisite listing
and trading approvals from the respective stock exchanges.
The Company has not accepted any deposits within the
meaning of Section 73 of the Act read with the Companies
(Acceptance of Deposits) Rules, 2014 as amended from time
to time.
In accordance with the provisions of Section 152(6) of the
Companies Act, 2013, Mr. Sameer V. Shah (DIN: 00105721)
Non-Executive Director, retires by rotation at the ensuing
Annual General Meeting, and being eligible, has offered
himself for re-appointment. His profile is detailed in the
Corporate Governance Report, which forms a part of this
Annual Report.
Mrs. Rashmi Gavli (DIN: 08001649) resigned as a Non¬
Executive Director with effect from April 1, 2025. The Board
places on record its appreciation for her contributions during
her tenure with the Company.
The Board appointed Mrs. Anuradha Paraskar (DIN: 02331564)
and Prof. Aniruddha B. Pandit (DIN: 02471158) as Independent
Non-Executive Directors of the Company with effect from
April 1, 2025, for a term of five years. The Board appointed
Mr. Sushil U. Lakhani (DIN: 01578957) and Mr. Mahendra
K. Ghelani (DIN: 01108297) as Independent Non-Executive
Directors of the Company with effect from May 6, 2025, for a
period of five years. Their appointments were duly approved by
the Members through an Extraordinary General Meeting by the
requisite majority.
In terms of key managerial changes, the Company appointed
Mrs. Prachi Mahadik as its Chief Financial Officer with effect
from April 1, 2025, and Mr. Kiran Mukadam as its Company
Secretary and Compliance Officer with effect from May 6,
2025.
Pursuant to the provisions of Section 203 of the Companies
Act, 2013, Mr. Nirmal V. Shah, Chairman and Managing
Director; Mrs. Prachi Mahadik, Chief Financial Officer; and Mr.
Kiran Mukadam, Company Secretary and Compliance Officer
are the Key Managerial Personnel of the Company as on the
date of this Report.
All the Independent Directors of the Company have furnished
a declaration to the effect that they meet the criteria of
independence as provided in Section 149(6) of the Act and
Regulation 16(1)(b) and Regulation 25 of the Listing Regulations.
The Board opines that all the Independent Directors possess
the integrity, expertise, experience, and proficiency required
to be Independent Directors of the Company, fulfil the
conditions of independence as specified in the Act and the
Listing Regulations, are independent of the management,
and have complied with the Code for Independent Directors
as prescribed in Schedule IV of the Act. Declaration of their
independence as required under the Listing Regulations have
also been received from the Directors.
The Company has put in place an appropriate policy on
appointment and remuneration of Directors and other matters
provided under Section 178(3) of the Act. This policy is uploaded
on the Companyâs website https://www.chembondindia.com/
all-policies/. Salient features of the policy on remuneration of
Directors have been disclosed in the Corporate Governance
section of this Annual Report.
Four (4) meetings of the Board were held during the year
under review, details of which are furnished in the Corporate
Governance Report forming part of the Annual Report.
During the year under review, the provisions relating to
the Nomination and Remuneration Committee and the
requirement for a separate meeting of Independent Directors
were not applicable to the Company. Accordingly, the
evaluation of the performance of Non-Independent Directors,
the Board as a whole, and the Chairman was not required.
Correspondingly, the assessment of the quality, quantity, and
timeliness of the flow of information to the Board, as reviewed
by the Independent Directors for the effective and reasonable
discharge of its duties, was also not applicable.
Pursuant to Section 134(5) of the Act, the Board of Directors,
to the best of their knowledge and ability, in respect of the year
ended 31st March, 2025, confirm that:
(a) in the preparation of the annual accounts, the applicable
accounting standards have been followed and there are
no material departures;
(b) they had selected such accounting policies and applied
them consistently and made judgments and estimates
that are reasonable and prudent so as to give a true and
fair view of the state of affairs of the Company at the end
of the financial year and of the profit of the Company for
that period;
(c) they took proper and sufficient care for the maintenance
of adequate accounting records in accordance with the
provisions of this Act for safeguarding the assets of the
Company and for preventing and detecting fraud and
other irregularities;
(d) they prepared the annual accounts on a going concern
basis;
(e) they laid down internal financial controls to be followed
by the Company and that such internal financial controls
are adequate and were operating effectively; and
(f) they devised proper systems to ensure compliance
with the provisions of all applicable laws and that such
systems were adequate and operating effectively.
The details in respect of role/powers/composition of the
Audit Committee and other information are included in the
Corporate Governance Report forming part of this Annual
Report.
M/s. Bathiya & Associates, LLP, Chartered Accountants
(FRN:101046W/W100063) name changed to S H B A & CO
LLP were appointed for first term as the Statutory Auditor of
the Company for a period of 5 (five) consecutive years at the
1st Annual General Meeting (AGM) held on July 20, 2024 until
the conclusion of the 6th AGM to be held in the FY 2029 at a
remuneration as may be mutually agreed upon by the Board of
Directors and the Statutory Auditor.
The Report given by the Auditors on the financial statements
of the Company is part of this Report. There has been no
modified opinion, qualification, reservation, adverse remark
or disclaimer given by the Auditors in their Report during the
year under review and the observations and comments given
in the report of the Statutory Auditors read together with Notes
to Accounts are self-explanatory and hence do not call for any
further explanation or comments under Section 134 (f)(i) of
the Act.
During the year under review, the Statutory Auditor, Cost
Auditor and Secretarial Auditor have not reported any
instances of frauds committed in the Company by its officers
or employees, to the Audit Committee under Section 143(12)
of the Act details of which needs to be mentioned in this
Annual Report.
The Company has been carrying on its domestic and
international operations through its wholly owned subsidiaries,
step-down subsidiaries, and step-down associate Companies.
The details of financial performance of these companies are
given in AOC-I as Annexure A.
Further, pursuant to the provisions of Section 136 of the
Act, the standalone financial statements of the Company,
consolidated financial statements along with relevant
documents and separate audited financial statements in
respect of subsidiaries, are available on the Companyâs
website https://www.chembondindia.com/subsidiary-
financials/.
Pursuant to the Composite Scheme of Arrangement and
NCLT order dated April 7, 2025, Chembond Clean Water
Technologies Ltd stands amalgamated on May 3, 2025.
All transactions entered into with related parties during the
financial year were in the ordinary course of business and on
armâs length basis and do not attract the provisions of Section
188(1) of the Act. Suitable disclosures as required by the
Indian Accounting Standards (Ind AS-24) have been made in
the notes to the Financial Statements. The Board has a policy
for related party transactions which has been uploaded on the
Companyâs website https://www.chembondindia.com/all-
policies/. Material RPT entered during the year are attached
as Annexure B in Form No. AOC-2, prescribed under the
provisions of Section 134(3)(h) of the Act and Rule 8 of the
Companies (Accounts) Rules, 2014.
The Conservation of Energy, Technology Absorption,
Foreign Exchange Earnings and Outgo
The particulars relating to conservation of energy, technology
absorption and foreign exchange earnings and outgo, as
required to be disclosed under Section 134(3)(m) of the Act
read with Rule 8(3) of the Companies (Account) Rules, 2014,
as amended from time to time, are provided in Annexure C.
Pursuant to Section 135 of the Act read with the Companies
(Corporate Social Responsibility Policy) Rules, 2014 as
amended from time to time, the Board of Directors of
the Company has duly constituted the Corporate Social
Responsibility (CSR) Committee, adopted CSR policy. The
CSR policy is available on Companyâs website at https://www.
chembondindia.com/all-policies/.
During the year, the Company was not subject to the
Corporate Social Responsibility (CSR) spending obligation,
as it did not meet the eligibility criteria prescribed under
Section 135(1) of the Companies Act, 2013. However, the CSR
obligations were applicable to Chembond Water Technologies
Limited (WOS) and Chembond Clean Water Technologies
Limited which was amalgamated with the Company on
May 3, 2025. These companies spent Rs. 47.96 lakhs and
Rs. 8.07 lakhs, respectively, on CSR activities during the financial
year 2024-25 through Visan Trust. The Company has identified
key focus areas for CSR engagement, which are detailed in the
Annual Report on CSR Activities, attached as Annexure D.
Pursuant to the provisions of Section 204 of the Act and the
Companies (Appointment and Remuneration of Managerial
Personnel) Rules, 2014, the Board of Directors of the Company
has appointed Mr. Virendra G. Bhatt, Practicing Company
Secretary (C.P. No.: 124) to undertake the Secretarial Audit
of the Company for the year ended 31st March, 2025. The
Company has received their written consent and confirmation
that the appointment will be in accordance with the applicable
provisions of the Act and rules framed thereunder.
The Secretarial Audit Report in Form MR- 3 for the Financial
Year ended 31st March, 2025 has been annexed as Annexure
E. The Company has complied with the applicable Secretarial
Standards issued by the Institute of Company Secretaries
of India (ICSI) during the year under review. There are no
qualification, reservation, adverse remark or disclaimer given
by the Secretarial auditor in their report for the year under
review.
Information regarding Directorsâ Remuneration Policy &
criteria for determining qualifications, positive attributes,
independence of a director and other matters provided under
sub-section (3) of Section 178 are provided in the Corporate
Governance Report.
The statement containing particulars of employees as
required under Section 197 of the Act read with Rule 5(2) of the
Companies (Appointment and Remuneration of Managerial
Personnel) Rules, 2014, as amended, will be provided
upon request to the Company. None of the employees of
the Company are being paid remuneration exceeding the
prescribed limit under the said provisions and Rules.
In terms of Section 136 of the Act, the Report and Accounts
are being sent to the members and others entitled thereto,
excluding the information on employeesâ particulars which
is available for inspection by the members at the registered
office of the Company during business hours on working days
of the Company up to the date of the ensuing Annual General
Meeting
In terms of the provisions of the Act and the Listing Regulations,
the Company has adopted all the applicable policies. The
policies are available on the website of the Company at
https://www.chembondindia.com/all-policies/.
All Directors and Senior Management Personnel have affirmed
their adherence to the provisions of the Code of Conduct
during the FY 2024-25. The Companyâs policy on Directorsâ
appointment, remuneration and other matters provided
in Section 178(3) of the Act forms part of Nomination and
Remuneration Policy and has been disclosed in the Corporate
Governance Report.
As per the requirements of the Listing Regulations, a Risk
Management Committee was constituted voluntarily with
responsibility of preparation of Risk Management Plan,
reviewing and monitoring the same on regular basis, to identify
and review critical risks on regular basis, to report key changes
in critical risks to the Board on an on-going basis, to report
critical risks to Audit Committee in detail on yearly basis and
such other functions as may be prescribed by the Board. The
Company has its Risk Management Policy in place which is
also displayed on the website of the Company i.e. https://
www.chembondindia.com/all-policies/.
The Board is responsible for establishing and maintaining
adequate internal financial control as per Section 134 of
the Act. Your Company has in place an adequate system of
internal controls to ensure compliance with various policies,
practices and statutes. The Company maintains robust
internal financial controls systems and processes that are
commensurate with the size, nature, geographical spread and
complexities of its operation both at entity and process levels
of the Company.
Management Discussion and Analysis Report for the year
under review, as stipulated under the Listing Regulations, is
presented , forming part of this Annual Report.
A separate Corporate Governance Report on compliance
with Corporate Governance requirements as required
under Regulation 34(3) read with Schedule V of the Listing
Regulations forms part of this Annual Report. The same has
been reviewed and certified by Mr. Virendra G. Bhatt, Practicing
Company Secretary, the Secretarial Auditor of the Company
and Compliance Certificate in respect thereof is enclosed.
The Company has formulated a Whistle Blower Policy,
details of which are furnished in the Corporate Governance
Report, thereby establishing a vigil mechanism for Directors
and permanent employees for reporting genuine concerns
or grievances, if any, about unethical behaviour, actual or
suspected fraud or violation of Companyâs Code of Conduct
or policies. It also provides adequate safeguards against the
victimization of employees and allows direct access to the
chairperson of Audit Committee in appropriate or exceptional
cases. The vigil mechanism / whistle blower policy is available
on Companyâs website https://www.chembondindia.com/all-
policies/.
Details of loans, guarantees and investments have been
disclosed in the Financial Statements.
The Company has in place an Anti-Sexual Harassment Policy
in line with the requirements of the Sexual Harassment of
Women at Workplace (Prevention, Prohibition and Redressal)
Act, 2013. The policy for Prevention of Sexual Harassment at
workplace is available on the website of the Company https://
www.chembondindia.com/all-policies. Internal Complaints
Committee (ICC) has been set up to redress complaints
received regarding sexual harassment. All employees
(permanent, contractual, temporary and trainees) are covered
under this policy. They are also provided training about the
Act. During the year under review, no complaint was received.
The Business Responsibility and Sustainability Report for the
year ended 31st March, 2025 as stipulated under Regulation 34
of the Listing Regulations is not applicable to the Company.
Except as disclosed elsewhere in the Report, there have
been no material changes and commitment affecting (except
mentioned in share capital , name change and scheme of
arrangement related point) , the financial position of your
Company, which have occurred between the end of the
financial year of the Company and the date of this Report.
During the year under review, there is no pending litigation
against the Company and its Directors. There has been no
significant and material order passed by the Regulators or
Courts or Tribunals impacting the going concern status of the
Company and its future operations.
The Company recognizes the need to have well-equipped
R&D facilities to meet customer requirements and to develop
cutting edge products. As a natural corollary, your Company
continues to invest in a R&D programme with processes that
suit the business and strategy of the Company.
The Board of Directors places on record its sincere appreciation
for the hard work, dedication, and commitment demonstrated
by its personnel across all levels of the organization. The
Board also gratefully acknowledges the continued support
and cooperation extended by the bankers, suppliers, business
partners, members, various government authorities, and all
other stakeholders who have contributed to the Companyâs
progress.
By Order of the Board of Director
of Chembond Chemicals Limited
(formerly Chembond Chemical Specialties Limited)
Chairman & Managing Director
June 30, 2025, Navi Mumbai DIN-00083853
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article